Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.33 HKD | 0.00% | 0.00% | -46.77% |
Apr. 12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
Apr. 08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.77% | 54.62M | |
+2.49% | 96.73B | |
-0.61% | 21.31B | |
-16.61% | 21.21B | |
-5.43% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Biopharmaceuticals' COVID-19 Booster Candidate Neutralizes Omicron Subvariant in Phase 3 Trial